Reduction of prostaglandin transporter predicts poor prognosis associated with angiogenesis in gastric adenocarcinoma.
Takeda S, Tanigawa T, Watanabe T, Tatsuwaki H, Nadatani Y, Otani K, Nagami Y, Tanaka F, Kamata N, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, Muguruma K, Ohira M, Hirakawa K, Arakawa T.
Takeda S, et al. Among authors: otani k.
J Gastroenterol Hepatol. 2016 Feb;31(2):376-83. doi: 10.1111/jgh.13079.
J Gastroenterol Hepatol. 2016.
PMID: 26250887